Milestone Pharmaceuticals’ CARDAMYST: A Promising Buy with FDA Decision and Phase 3 Trial on Horizon
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
Le Lézard9h
PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by Advancements in Drug Delivery: - Market Research Intellect
The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...
Viridian Therapeutics: Promising FcRn Inhibitor Developments and Strong Buy Recommendation
Leerink Partners analyst Thomas Smith reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report) on November 12 and set a ...